STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Companies Large-Cap
semiconductor-7

Citi Boosts Nvidia Target on Soaring Global AI Demand

byLuca Blaumann
July 7, 2025
in Large-Cap, Semiconductors
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Sovereign investments and enterprise AI buildouts drive bullish outlook as Nvidia nears $4 trillion market cap

Citi is doubling down on Nvidia (NVDA), raising its price target to $190 per share — a 15% upside from current levels — as demand for AI infrastructure continues to surge, especially from sovereign governments. The move reflects growing confidence that Nvidia will capture a larger share of a rapidly expanding market, cementing its position as a cornerstone of global AI deployment.

“We believe sovereign demand is already contributing up to billions of dollars in 2025,” wrote Citi analysts Atif Malik and Papa Sylla. “Nvidia is involved in essentially every sovereign deal,” they added, highlighting the company’s pivotal role in national AI infrastructure buildouts.

Citi raised its 2028 total addressable market (TAM) estimate for AI compute to $563 billion, up 13% from prior forecasts. Networking TAM was also boosted to $119 billion from $90 billion, signaling higher expectations for Nvidia’s data center and networking businesses.

Nvidia’s Generative AI conference further bolstered the bullish case. Attendees discussed a benchmark for AI infrastructure: one supercomputer or 10,000 GPUs per 100,000 employees — a ratio that could accelerate AI adoption across governments and large enterprises. With Nvidia’s Blackwell GB200 chips already powering many of these clusters, Citi noted that deployment is ramping up swiftly and that previous concerns about supply chain bottlenecks are easing.

Looking ahead, Citi expects Nvidia’s data center revenue to grow 5% in FY 2027 and 11% in FY 2028, with networking revenue surging 12% and 27%, respectively. Gross margins are forecast to normalize in the mid-70% range by year-end.

While risks remain — particularly potential export restrictions if a second Trump administration emerges — Citi remains optimistic. Reports suggest that Malaysia and Thailand may come under scrutiny for routing advanced chips to China, but these geopolitical headwinds have yet to dent the broader AI boom.

“Nvidia has line of sight to tens of gigawatts of sovereign and enterprise AI factory buildouts over the next few years,” the analysts wrote.

With its stock up 12% over the past month and a market cap approaching $4 trillion, Nvidia continues to ride the wave of the AI revolution — and Citi sees plenty more upside ahead.

You might like this article:Regencell Bioscience’s Stock Whipsaws Again Amid 17,000% Surge in 2025

Tags: analystCCitiGrowthMoversNewsNVDANvidiaStock Market
Previous Post

Regencell Bioscience’s Stock Whipsaws Again Amid 17,000% Surge in 2025

Next Post

KULR Technology Secures $20 Million Bitcoin-Backed Credit Facility from Coinbase

Related Posts

Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom

byLuca Blaumann
March 12, 2026
0

Strategic partnerships, expanding capacity, and Nvidia backing highlight growing momentum in the neocloud sector Investor confidence is increasing in AI...

Rivian Electric Pickup Truck

Rivian Unveils R2 Pricing and Trim Levels as It Targets the Mass EV Market

byLuca Blaumann
March 12, 2026
0

Performance and Premium models arrive first, while the most affordable R2 won’t reach buyers until 2027 Electric vehicle maker Rivian...

investing

Oracle Shares Surge After Strong Earnings and Ambitious AI Growth Outlook

byLuca Blaumann
March 11, 2026
0

Cloud performance and raised 2027 revenue target fuel investor optimism despite heavy AI infrastructure spending Oracle Corporation (ORCL) saw its...

Next Post
bitcoin-1

KULR Technology Secures $20 Million Bitcoin-Backed Credit Facility from Coinbase

Latest News

bioAffinity Technologies Stock Surges 120% as CyPath Lung Sales Accelerate

Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom

Rivian Unveils R2 Pricing and Trim Levels as It Targets the Mass EV Market

Tilman Fertitta in Exclusive Talks to Acquire Caesars Entertainment

Acurx Pharmaceuticals Shares Rise on New Clinical Trial Plans

Based on Your Interest

investing
IT Services

Oracle Shares Surge After Strong Earnings and Ambitious AI Growth Outlook

March 11, 2026
amazon-2
Ecommerece

Amazon Launches Massive Bond Offering to Fuel AI Expansion

March 10, 2026
trading-chart
Electric

ATPC Expands Global Energy Ambitions Through Strategic Partnership with Citadel Investment

March 10, 2026

Recommended

Crypto

Ethereum’s Bull Case: Why Analysts See a Path to $5,000

March 9, 2026
Biotechnology

Hims & Hers Stock Soars After Strategic Partnership With Novo Nordisk

March 9, 2026
Economy

Gold Retreats as Stronger Dollar and Rising Oil Pressure Markets

March 9, 2026
Internet

Tech Giants Maintain AI Partnerships With Anthropic Despite Pentagon Blacklist

March 6, 2026
Semiconductors

Peraso’s 60 GHz Technology Powers Next-Generation Military Drone Identification System

March 6, 2026
Stoxpo

Follow us on social media:

Highlights

  • bioAffinity Technologies Stock Surges 120% as CyPath Lung Sales Accelerate
  • Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom
  • Rivian Unveils R2 Pricing and Trim Levels as It Targets the Mass EV Market
  • Tilman Fertitta in Exclusive Talks to Acquire Caesars Entertainment
  • Acurx Pharmaceuticals Shares Rise on New Clinical Trial Plans

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

bioAffinity Technologies Stock Surges 120% as CyPath Lung Sales Accelerate

March 13, 2026

Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom

March 12, 2026
Rivian Electric Pickup Truck

Rivian Unveils R2 Pricing and Trim Levels as It Targets the Mass EV Market

March 12, 2026
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.